OSX Share Price Performance
Recent OSX News & Updates
No updates
Osteopore Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.016
- Gross Margin
- 83.08%
- Net Profit Margin
- -121.34%
- Debt/Equity Ratio
- 379.9%
Osteopore Limited Competitors
About OSX
- Founded
- 2003
- Employees
- n/a
- CEO
- WebsiteView website
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical implants; sells medical devices; provides technology services; and engages in research and development activities. Osteopore Limited was founded in 2003 and is headquartered in Singapore.
Singaporean Market Performance
- 7 Days: -2.7%
- 3 Months: 9.1%
- 1 Year: 21.2%
- Year to Date: 10.6%
Over the last 7 days, the market has dropped 2.7%, driven by a loss of 2.4% in the Financials sector. In the last year, the market is actually up 21%. Looking forward, earnings are forecast to grow by 7.1% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading